Startups in the second cohort of the Mission from MaRS: Better Buildings Adoption Accelerator are working on viable ways to decarbonize existing homes and construct more sustainable new ones.

According to the Canadian Cancer Society, rare cancers make up around 20 percent of new cancer cases in Canada. Learn how the Ontario Institute for Cancer Research and Calgary-based Providence Therapeutics are harnessing mRNA technology to advance treatments for rare cancers and other conditions.

To ensure your company’s information remains secure, the key question to ask is “who can access your data?” says Jordan Thompson, senior vice president of product development at cybersecurity firm Fortinet.

Gene therapy has been around for decades. But an experimental new approach has scientists believing we’re on the cusp of a medical revolution. On this episode of Solve for X, host Manjula Selvarajah dives into what this could mean for patients.